K823-2608 Screening compound: N-(4-fluorophenyl)-5-methyl-4-oxo-3-{2-oxo-2-[4-(pyridin-2-yl)piperazin-1-yl]ethyl}-3H,4H-thieno[2,3-d]pyrimidine-6-carboxamide

K823-2608 Screening compound: N-(4-fluorophenyl)-5-methyl-4-oxo-3-{2-oxo-2-[4-(pyridin-2-yl)piperazin-1-yl]ethyl}-3H,4H-thieno[2,3-d]pyrimidine-6-carboxamide
K823-2608 Screening compound: N-(4-fluorophenyl)-5-methyl-4-oxo-3-{2-oxo-2-[4-(pyridin-2-yl)piperazin-1-yl]ethyl}-3H,4H-thieno[2,3-d]pyrimidine-6-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound K823-2608
N-(4-fluorophenyl)-5-methyl-4-oxo-3-{2-oxo-2-[4-(pyridin-2-yl)piperazin-1-yl]ethyl}-3H,4H-thieno[2,3-d]pyrimidine-6-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

K823-2608

Molecular Formula

C25H23FN6O3S (C25 H23 FN6 O3 S)

Compound Name

N-(4-fluorophenyl)-5-methyl-4-oxo-3-{2-oxo-2-[4-(pyridin-2-yl)piperazin-1-yl]ethyl}-3H,4H-thieno[2,3-d]pyrimidine-6-carboxamide

IUPAC name

N-(4-fluorophenyl)-5-methyl-4-oxo-3-{2-oxo-2-[4-(pyridin-2-yl)piperazin-1-yl]ethyl}-3H4H-thieno[23-d]pyrimidine-6-carboxamide

SMILES

Cc1c(C(Nc(cc2)ccc2F)=O)sc(N=CN2CC(N(CC3)CCN3c3ncccc3)=O)c1C2=O

InChI

InChI=1S/C25H23FN6O3S/c1-16-21-24(36-22(16)23(34)29-18-7-5-17(26)6-8-18)28-15-32(25(21)35)14-20(33)31-12-10-30(11-13-31)19-4-2-3-9-27-19/h2-9,15H,10-14H2,1H3,(H,29,34)

InChI Key

WIZJPUPUXLRIOX-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD15109750

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

506.56

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

2.484

Distribution Coefficient, logD

2.425

Water Solubility, LogSw

-2.76

Polar Surface Area

77.497

Acid Dissociation Constant (pKa)

8.31

Base Dissociation Constant (pKb)

5.71

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

24.00

K823-2608 in Drug Discovery

Included in Screening Libraries

Nucleic Acid Ligands (8311 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

Epigenetics Focused Set (26518 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Infections
  • Cancer
  • Musculoskeletal
  • Nervous system
  • Hemic and lymphatic
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with K823-2608 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound K823-2608?
Check Price and Availability of K823-2608, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of K823-2608 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for K823-2608
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for K823-2608
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of K823-2608 available by request